🇺🇸 Iron Sucrose IV in United States
7 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 7
Most-reported reactions
- Cardiac Flutter — 1 report (14.29%)
- Death — 1 report (14.29%)
- Dyspnoea — 1 report (14.29%)
- Enterocolitis — 1 report (14.29%)
- Febrile Neutropenia — 1 report (14.29%)
- Lower Gastrointestinal Haemorrhage — 1 report (14.29%)
- Palpitations — 1 report (14.29%)
Other Hematology approved in United States
Frequently asked questions
Is Iron Sucrose IV approved in United States?
Iron Sucrose IV does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Iron Sucrose IV in United States?
CN NGANOU-GNINDJIO, MD, MSc is the originator. The local marketing authorisation holder may differ — check the official source linked above.